ID

34581

Beschrijving

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp; ODM derived from: https://clinicaltrials.gov/show/NCT02189694

Link

https://clinicaltrials.gov/show/NCT02189694

Trefwoorden

  1. 19-01-19 19-01-19 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

19 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 1 Diabetes NCT02189694

Eligibility Type 1 Diabetes NCT02189694

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
males or females between the 8 and 17 years of old.
Beschrijving

ID.1

Datatype

boolean

clinical diagnosis of type 1 diabetes for at least one year. the subject will have been on insulin pump therapy for at least 3 months.
Beschrijving

ID.2

Datatype

boolean

hba1c ≤ 11.0%.
Beschrijving

ID.3

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinically significant nephropathy, neuropathy or retinopathy as judged by the investigator.
Beschrijving

ID.4

Datatype

boolean

severe hypoglycemic episode within two weeks of inclusion in the study. a severe hypoglycemic episode is defined as loss of conscience, seizure or a hospital emergency visit.
Beschrijving

ID.5

Datatype

boolean

current use of oral glucocorticoid medication (except low stable dose according to investigator judgement). stable doses of inhaled steroids are acceptable.
Beschrijving

ID.6

Datatype

boolean

known or suspected allergy to the trial products.
Beschrijving

ID.7

Datatype

boolean

other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
Beschrijving

ID.8

Datatype

boolean

failure to comply with team's recommendations (e.g. not willing to use trial pump, etc).
Beschrijving

ID.9

Datatype

boolean

Similar models

Eligibility Type 1 Diabetes NCT02189694

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
males or females between the 8 and 17 years of old.
boolean
ID.2
Item
clinical diagnosis of type 1 diabetes for at least one year. the subject will have been on insulin pump therapy for at least 3 months.
boolean
ID.3
Item
hba1c ≤ 11.0%.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
clinically significant nephropathy, neuropathy or retinopathy as judged by the investigator.
boolean
ID.5
Item
severe hypoglycemic episode within two weeks of inclusion in the study. a severe hypoglycemic episode is defined as loss of conscience, seizure or a hospital emergency visit.
boolean
ID.6
Item
current use of oral glucocorticoid medication (except low stable dose according to investigator judgement). stable doses of inhaled steroids are acceptable.
boolean
ID.7
Item
known or suspected allergy to the trial products.
boolean
ID.8
Item
other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
boolean
ID.9
Item
failure to comply with team's recommendations (e.g. not willing to use trial pump, etc).
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial